| Novel Approaches for Improving Vascular Function in Veterans With HFpEF (NCT06312748) | VA Office of Research and Development | 2021-05-19 |
| ALY688-SR in Generally Healthy Overweight or Obese Adults (NCT04855565) | Allysta Pharmaceutical | 2021-05-19 |
| Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa (NCT03944239) | Qi Zhou | 2021-05-19 |
| Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma (NCT04822337) | Wake Forest University Health Sciences | 2021-05-19 |
| The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere (NCT04811118) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-05-18 |
| A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface (NCT04752215) | Boehringer Ingelheim | 2021-05-18 |
| Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis (NCT04815902) | Steadman Philippon Research Institute | 2021-05-18 |
| Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome (NCT04496960) | National Institute of Dental and Craniofacial Research (NIDCR) | 2021-05-18 |
| BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL (NCT04690595) | PeproMene Bio, Inc. | 2021-05-18 |
| A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men (NCT04878406) | Novo Nordisk A/S | 2021-05-18 |
| Sequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma (NCT04850560) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-05-18 |
| A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects (NCT04839744) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-05-18 |
| Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® (NCT04896853) | NextCell Pharma Ab | 2021-05-18 |
| A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food (NCT04789291) | Boehringer Ingelheim | 2021-05-18 |
| A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors (NCT04857138) | Hoffmann-La Roche | 2021-05-18 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis (NCT04544943) | Hoth Therapeutics, Inc. | 2021-05-17 |
| QA102 Phase 1 Study in Healthy Young and Older Adult Subjects (NCT04894071) | Smilebiotek Zhuhai Limited | 2021-05-17 |
| A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated (NCT04866160) | Boehringer Ingelheim | 2021-05-17 |
| A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults (NCT04883333) | LEO Pharma | 2021-05-17 |
| Safety and Tolerability of TWP-201 in Healthy Female Subjects (NCT04878705) | Shandong TheraWisdom Biopharma Co., Ltd. | 2021-05-17 |
| A Study to Evaluate Lemborexant in Milk of Healthy Lactating Women (NCT04890561) | Eisai Inc. | 2021-05-17 |
| Safety and Efficacy of R0.6C Vaccine (NCT04862416) | Radboud University Medical Center | 2021-05-17 |
| Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders (NCT04548791) | Catalyst Biosciences | 2021-05-17 |
| Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations (NCT04814472) | Blade Therapeutics | 2021-05-16 |
| Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy (NCT04882592) | SpineX Inc. | 2021-05-15 |
| OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut (NCT04603300) | Intrommune Therapeutics | 2021-05-15 |
| Neural Response to Inflammatory Challenge in Major Depressive Disorder (NCT04751331) | Laureate Institute for Brain Research, Inc. | 2021-05-15 |
| Effects of Nystatin Suspension Oral Application on Oral Microbial Community (NCT04550546) | University of Rochester | 2021-05-15 |
| Double Filtration Plasmapheresis Combined With Chemotherapy (NCT04836871) | Fuling Zhou | 2021-05-15 |
| Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients (NCT05046665) | South Metropolitan Health Service | 2021-05-14 |
| The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects (NCT04829123) | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 2021-05-14 |
| A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants (NCT04881747) | Eli Lilly and Company | 2021-05-14 |
| First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies (NCT04763083) | NovalGen Ltd. | 2021-05-14 |
| Study of LVGN6051 (CD137 Agonist Antibody) in Advanced or Metastatic Malignancy (NCT04694781) | Lyvgen Biopharma Holdings Limited | 2021-05-14 |
| Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects (NCT05181215) | Banner Life Sciences LLC | 2021-05-14 |
| Evaluate the Effect of Tirazamine on Primary Liver Cancer. (NCT06848556) | Zhejiang Raygene Pharmaceuticals Co., Ltd | 2021-05-14 |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma (NCT04757662) | Washington University School of Medicine | 2021-05-14 |
| Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension (NCT05297968) | The Affiliated Hospital of Qingdao University | 2021-05-13 |
| Study of ON 123300 in Patients With Advanced Cancer (NCT04739293) | Traws Pharma, Inc. | 2021-05-13 |
| Study in Healthy Adults Evaluating PF-07202954 (NCT04857437) | Pfizer | 2021-05-13 |
| Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite (NCT04902105) | Emalex Biosciences Inc. | 2021-05-13 |
| A Study of FCN-338 in Patients With Chronic CLL/SLL (NCT04682808) | Fochon Pharmaceuticals, Ltd. | 2021-05-13 |
| A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers (NCT04931147) | Redx Pharma Ltd | 2021-05-13 |
| Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China (NCT04976751) | Xijing Hospital | 2021-05-13 |
| Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (NCT04634539) | Jun Gong, MD | 2021-05-13 |
| Pharmacokinetics of PN-232 in Healthy Volunteers (NCT04819620) | Protagonist Therapeutics, Inc. | 2021-05-13 |
| A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers. (NCT04564092) | GE Healthcare | 2021-05-13 |
| Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants (NCT04896632) | Novartis Pharmaceuticals | 2021-05-13 |
| A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma. (NCT04835805) | Genentech, Inc. | 2021-05-13 |
| A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency (NCT05154890) | Aeglea Biotherapeutics | 2021-05-13 |
| Novel Imaging Technique to Assess Gynecologic Cancer (NCT04893434) | Memorial Sloan Kettering Cancer Center | 2021-05-13 |
| A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients (NCT04688853) | Gadeta B.V. | 2021-05-13 |
| Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer (NCT04803851) | Peking Union Medical College Hospital | 2021-05-12 |
| A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. (NCT04865835) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2021-05-12 |
| Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects (NCT04881955) | Emalex Biosciences Inc. | 2021-05-12 |
| A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery (NCT04660721) | Sealantium Medical Ltd. | 2021-05-12 |
| Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury (NCT05398913) | Hospital Nacional de Parapléjicos de Toledo | 2021-05-12 |
| Lung Cancer With Copanlisib and Durvalumab (NCT04895579) | Zhonglin Hao | 2021-05-12 |
| Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy (NCT05308732) | Instituto Nacional de Cancer, Brazil | 2021-05-11 |
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia (NCT04803305) | Pfizer | 2021-05-11 |
| A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis (NCT04273269) | LYSOGENE | 2021-05-11 |
| FHD-286 in Subjects With Metastatic Uveal Melanoma (NCT04879017) | Foghorn Therapeutics Inc. | 2021-05-11 |
| A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571. (NCT04866225) | Pfizer | 2021-05-11 |
| The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC (NCT04929080) | Shanghai Junshi Bioscience Co., Ltd. | 2021-05-11 |
| Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study (NCT04500548) | National Cancer Institute (NCI) | 2021-05-11 |
| A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose (NCT04872387) | Bayer | 2021-05-11 |
| Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) (NCT04889274) | Queen Mary University of London | 2021-05-10 |
| Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study) (NCT04718441) | David Mooney | 2021-05-10 |
| Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers (NCT04906005) | Guerbet | 2021-05-10 |
| Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer (NCT04590781) | Xencor, Inc. | 2021-05-10 |
| An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. (NCT04660812) | Arcus Biosciences, Inc. | 2021-05-10 |
| RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma (NCT04762225) | Repertoire Immune Medicines | 2021-05-10 |
| Study of a New Technique for Imaging Pancreatic Cancer (NCT04883775) | Memorial Sloan Kettering Cancer Center | 2021-05-10 |
| Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML (NCT04588922) | Sellas Life Sciences Group | 2021-05-10 |
| Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions (NCT04882826) | Pharmtechnology LLC | 2021-05-10 |
| Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study) (NCT04905511) | Vascudyne, Inc. | 2021-05-10 |
| Stool Transplant to Control Treatment-related Diarrhea (NCT04883762) | Memorial Sloan Kettering Cancer Center | 2021-05-10 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults (NCT05275660) | HiFiBiO Therapeutics | 2021-05-09 |
| A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects (NCT04973189) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-05-08 |
| Pergoveris FD and Liquid China BE Study (NCT04899193) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2021-05-08 |
| A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682) | Jacobio Pharmaceuticals Co., Ltd. | 2021-05-07 |
| Recombinant Human Alkaline Phosphatase in Healthy Japanese Subjects (NCT04923282) | AM-Pharma | 2021-05-07 |
| A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Malignancy (NCT04795128) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-05-07 |
| A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma (NCT04834973) | QBiotics Group Limited | 2021-05-07 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension (NCT04885491) | Attgeno AB | 2021-05-07 |
| Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler (NCT04856098) | Orion Corporation, Orion Pharma | 2021-05-07 |
| A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants (NCT04827134) | ViiV Healthcare | 2021-05-07 |
| A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors (NCT04866134) | Erasca, Inc. | 2021-05-07 |
| Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer (NCT04882033) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-07 |
| KRT-232 and TKI Study in Chronic Myeloid Leukemia (NCT04835584) | Kartos Therapeutics, Inc. | 2021-05-07 |
| A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure (NCT04846816) | SQ Innovation, Inc. | 2021-05-06 |
| To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. (NCT04848662) | Bond Avillion 2 Development LP | 2021-05-06 |
| A Pharmacokinetic Study of TP-05 in Healthy Subjects (NCT05138796) | Tarsus Pharmaceuticals, Inc. | 2021-05-06 |
| Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers (NCT04967014) | Hanmi Pharmaceutical Company Limited | 2021-05-06 |
| huCART19-IL18 in CD19+ Cancers (NCT04684563) | University of Pennsylvania | 2021-05-06 |
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (NCT04431258) | Ability Pharmaceuticals SL | 2021-05-06 |
| Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies (NCT04865159) | Kura Oncology, Inc. | 2021-05-06 |
| Treat COVID-19 Patients With Regadenoson (NCT04606069) | University of Maryland, Baltimore | 2021-05-06 |
| Study of LM-061 in Subjects in Advanced Tumors (NCT04737122) | LaNova Medicines Limited | 2021-05-06 |
| A Phase I Safety Study of NVG-291 in Healthy Adults (NCT05308953) | NervGen Pharma | 2021-05-06 |